11
12M
7
1
0.36
- Stages of investment
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the MINTS, startups are often financed by Invest Michigan, V-Bio Ventures, The Institute for the Promotion of Innovation by Science and Technology in Flanders. The meaningful sponsors for the fund in investment in the same round are Invest Michigan, Wellington Partners, VIB. In the next rounds fund is usually obtained by Invest Michigan, University of Michigan MINTS fund, The Amherst Fund.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
Among the most successful fund investment fields, there are Medical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Fusion Coolant Systems, ONL Therapeutics, Confo Therapeutics The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Follow on index
- 0.36
- Investments by industry
- Health Care (6)
- Biotechnology (4)
- Therapeutics (4)
- Pharmaceutical (3)
- Clinical Trials (3) Show 15 more
- Investments by region
-
- United States (10)
- Belgium (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ONL Therapeutics | 08 Mar 2023 | Biotechnology, Pharmaceutical, Therapeutics | Late Stage Venture | 15M | United States, Ann Arbor, Michigan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.